London – pharmaceutical daily

February 9, 2017 Off

Amryt’s first full year as a public company, Cathal Friel leaves board

Amryt’s non-executive director Cathal Friel will step down from the board the last day of March 2017, the orphan diseases focused pharmaceutical company said Thursday.

February 8, 2017 Off

OptiBiotix to trade new shares on AIM (London)

By Dino Mustafić

OptiBiotix Health has been notified by from warrant holders to exercise warrants over 16,351 ordinary shares

November 27, 2015 Off

Exclusive: Lazard works with Sanofi on $12.7 billion animal health unit deal – sources

By Dino Mustafić

By Pamela Barbaglia, Olivia Oran and Arno Schuetze LONDON/NEW YORK/FRANKFURT (Reuters) – Investment bank Lazard is working with Sanofi’s management…